Role of prolactin in the modulation of NK and lak cell activity after short- or long-term morphine administration in neoplastic patients

https://doi.org/10.1016/S0192-0561(96)00059-8Get rights and content

Abstract

In a previous work we demonstrated that chronic in vivo antalgic therapy of cancer patients with morphine reduced the endogenous cytotoxic activity of natural killer (NK) cells, while increasing the development of lymphokine activated killer (LAK) cell cytotoxicity. In order to investigate the mechanisms by which morphine affects NK and LAK cell function further, we evaluated the modulation exerted by short- or long-term morphine administration on either NK/LAK cell cytotoxicities or plasma levels of prolactin (PRL) and other immunomodulating neurohormones. An intravenous morphine injection (10mg) significantly increased the plasma levels of PRL, reduced the cytotoxic activity of NK cells, and increased the development of LAK cell activity 30 min after drug injection in neoplastic patients. The administration of bromocriptine before the injection of morphine prevented both PRL augmentation and the increase in LAK cell activation, although it did not prevent the inhibition of NK cytotoxicity. The chronic oral administration of morphine (90±30mg/day for 1 month) also resulted in higher PRL levels; the NK and LAK cell activities were, respectively, lower than or higher than those found in neoplastic patients untreated with morphine. The plasma levels of thyrotropin (TSH), adrenocorticotropic hormone (ACTH) and cortisol were not significantly modified in either short- or long-term experiments. The absolute number and the percentages of lymphocyte populations, as well as the percentage of IL-2 receptors, were not modified after short-term morphine administration whereas little changes of T lymphocyte populations and NK cell number were observed after oral treatment with morphine. In vitro morphine did not affect the development of LAK cell activity. In conclusion, our findings indicate that morphine reduces NK cytotoxicity and increases the development of LAK cell cytotoxicity after short- and long-term administration. The effect of morphine on LAK cell activation but not on NK cell reduction is related to the modulation of PRL levels determined by the opioid drug.

References (42)

  • M. Provinciali et al.

    Optimization of cytotoxic assay by target cell retention of the fluorescent dye carboxyfluorescein diacetate (c'FDA) and comparison with conventional 51 CR-release assay

    J. Immun. Meth.

    (1992)
  • M. Provinciali et al.

    Improvement in the proliferative capacity and natural killer cell activity of murine spleen lymphocytes by thyrotropin

    Int. J. Immunopharmacol.

    (1992)
  • M. Provinciali et al.

    Models and mechanisms of neuroendocrine-immune interactions during ontogeny

    Adv. Neuroimmun.

    (1991)
  • P.K. Arora et al.

    Morphine-induced immune alterations

    Cell. Immun..

    (1990)
  • H.O. Besedovsky et al.

    Immune-neuroendocrine circuits: integrative role of cytokines

    Frontiers Neuroendocr.

    (1992)
  • G. Bocchini et al.

    Significance of biogenic amines for opioid-induced locomotor activity in rats

    Drug Alc. Depend.

    (1983)
  • S.M. Brown et al.

    Immunologic dysfunction in heroin addicts

    Arch. Intern. Med.

    (1974)
  • M.J. Estienne et al.

    Gonadotropin and prolactin secretion following intraventricular administration of morphine in gilts

  • D.O. Freier et al.

    A mechanism of action for morphine induced immunosuppression: corticosterone mediates morphine induced suppression of natural killer cell activity

    J. Pharmacol. Exp. Ther.

    (1994)
  • R. Gerli et al.

    Reduced number of natural killer cells in patients with pathological hyperprolactinemia

    Clin. Exp. Immun.

    (1986)
  • M. Gungor et al.

    Effect of chronic administration of morphine on primary immune response in mice

    Experientia

    (1980)
  • Cited by (0)

    View full text